Under the deal, Novo gets the right to use PharmaShell in as many as five development programs for peptide-based medicines targeting obesity, type 2 diabetes and other cardiometabolic diseases.
Matias Civita
Sep 25, 2026
Rosabella is making moringa simpler for people who want the nutritional benefits without the powder, preparation, or complicated routine.
Will Jones
Sep 25, 2026
Pew Research Center reported in 2025 that 91% of U.S. adults owned a smartphone, giving emergency technology a familiar device through which to reach people quickly.
Adam Bent
Sep 25, 2026
Every staffing decision, leadership transition, and process improvement unfolds alongside the immediate demands of patient care.
Callum Turner
Sep 24, 2026
According to the Health & Fitness Association, 81 million Americans held a fitness facility membership in 2025, a 5.2% increase from 2024.
Callum Turner
Sep 22, 2026
In 2024, an estimated 27.1 million people, or 8 percent of the U.S. population, did not have health insurance at any point during the year, according to the U.S. Census Bureau. The burden was considerably greater among people living in poverty.
Adam Bent
Sep 21, 2026
The Centers for Disease Control and Prevention's 2026 Yellow Book advises travelers with chronic illnesses to carry details of their conditions, medications, and allergies.
Callum Turner
Sep 18, 2026
U.S. data found that 24.3% of adults had chronic pain, while 8.5% experienced pain that frequently limited their life or work activities.
Callum Turner
Sep 17, 2026
Mercer's annual survey of employer-sponsored health plans projects that the total cost of health benefits per employee will increase by an average of 8.2% in 2027, the biggest increase since 2003.
Matias Civita
Sep 07, 2026
Nine midsize drugmakers joined the White House program and pledged at least $19.6 billion in U.S. manufacturing investments.
Merin Rebecca Thomas
Sep 01, 2026
The findings are based on more than 50,000 simulated conversations involving users experiencing severe mental health crises.
Matias Civita
Sep 01, 2026
Hume Health aims to revolutionize healthcare by helping users understand their long-term health in a more connected and actionable way.
Will Jones
Aug 24, 2026
Researchers are beginning clinical trials aimed at determining whether drugs such as tirzepatide and semaglutide can influence some of the biological processes associated with getting older.
Matias Civita
Aug 21, 2026
Kyle Robertson revolutionized virtual healthcare before he turned 30. With a new venture studio, he wants to improve traditional healthcare for the AI age.
Carl Williams
Aug 14, 2026
AI agents could accelerate the clinical development of cancer medicine by approximately 10 weeks while reducing direct operating costs by as much as $5.6 million in late-stage trials.
Matias Civita
Aug 13, 2026
Traditional posture correctors fail because they ignore torso length. Fit Geno's HeightFit patented height-adjustable design finally fixes the fit problem — here's how.
Carl Williams
Aug 12, 2026
Doximity's stock more than doubled in overnight trading following its fiscal first quarter 2027 earnings report, climbing more than 130% in premarket trading before declining to about 40%.
Matias Civita
Aug 07, 2026
Dawson believes the next era of healthcare will not be defined by treating more patients with the same recommendations, but by understanding every individual with greater biological precision.
Will Jones
Aug 06, 2026
U.S.-listed shares of Novo Nordisk fell more than 6% after the company raised its full-year 2026 outlook but signaled that sales and profit could still decline compared with the previous year.
Matias Civita
Aug 04, 2026
Erez Israeli, CEO of Dr. Reddy's Laboratories, said that President Donald Trump's proposed tariffs on imported generic medicines would inevitably translate into higher prices for patients.
Matias Civita
Jul 27, 2026
After 80 weeks of treatment, obese, non-diabetic participants receiving retatrutide lost an average of 22.6% of their body weight while also showing improvements in several cardiometabolic risk factors.
Matias Civita
Jul 23, 2026
A new economic study suggests that GLP-1 medications like Ozempic or Mounjaro could reduce employee sick leave, potentially saving money for both businesses and governments while improving workplace productivity.
Matias Civita
Jul 23, 2026
The lawsuit, filed Tuesday, alleges that Eli Lilly violated federal and state false advertising laws by promoting "knowingly outdated clinical trial" results that compare both companies' drugs.
Matias Civita
Jul 21, 2026
Artificial intelligence is rapidly transforming the pharmaceutical industry, dramatically reducing the time and cost required to develop new medicines before they ever reach human testing, according to a new survey.
Matias Civita
Jul 20, 2026
Eli Lilly is making its biggest move yet into the rapidly evolving field of psychedelic medicine, acquiring clinical-stage biotechnology company AtaiBeckley in a deal valued at up to $3.8 billion.
Matias Civita
Jul 16, 2026
Americans who buy health insurance through the Affordable Care Act marketplace could face another sharp increase in premiums next year, with insurers proposing a median 14% rate hike for 2027.
Matias Civita
Jul 08, 2026
The largest nurses strike in Massachusetts history began at Brigham and Women's Hospital as 4,000 nurses walked out over wages, benefits and staffing.
Pham Binh
Jul 08, 2026
From Abby's perspective, lasting progress depends on placing firsthand operational knowledge alongside advocacy, policy, and public engagement rather than limiting former abortion workers to sharing personal stories.
Adam Bent
Jul 01, 2026
Nutrition expert Sabrina Hernandez argues that longevity isn't built on restrictive diets but on sustainable habits, antioxidant-rich foods, and a healthier relationship with eating.
Callum Turner
Jun 26, 2026
Families facing aggressive cancers often find themselves navigating therapies that can be physically demanding, particularly when standard treatments are rendered futile.
Callum Turner
Jun 24, 2026